Abbott Laboratories Q3 Adjusted EPS $1.14 Beats $1.04 Estimate, Sales $10.14B Beat $9.32B Estimate
Portfolio Pulse from Benzinga Newsdesk
Abbott Laboratories reported Q3 earnings of $1.14 per share, beating the analyst consensus estimate of $1.04 by 9.62%. However, this is a 0.87% decrease from the same period last year. The company also reported quarterly sales of $10.14 billion, beating the estimate of $9.32 billion by 8.83%, but this is a 2.56% decrease from the same period last year.
October 18, 2023 | 11:32 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Abbott Laboratories reported better than expected Q3 earnings and sales, but both figures are down compared to the same period last year.
While Abbott Laboratories beat estimates for Q3 earnings and sales, the decrease from the same period last year could potentially concern investors. This mixed result makes the short term impact on the stock price uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100